Aug 12, 2021 / 05:00PM GMT
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Okay. Great. So welcome to our next session here in person with the management from Baxter. We've got Jay Saccaro, EVP and CFO of the company; and Clare Trachtman, VP of IR. So Jay and Clare, thanks for making the trip. Welcome to the live stage, the first time in a couple of years, so it's very exciting, and looking forward to the conversation.
Questions and Answers:
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & DevicesSo let me come and sit down with you. So first, I just wanted to start with a high-level question for you, Jay, and maybe just talk about your vision for Baxter over the next few years. Without giving away the Analyst Day takeaways, could you talk at a high level about how you see the evolution of Baxter post-COVID?
James K. Saccaro - Baxter International Inc. - Executive VP & CFO
Sure, Matt. And it's